• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C5a/C5aR 阻断可减轻 cGVHD,其机制与 Treg 频率增加有关。

Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg.

机构信息

Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, P. R. China.

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, 510060, P. R. China.

出版信息

Sci Rep. 2017 Jun 15;7(1):3603. doi: 10.1038/s41598-017-03700-1.

DOI:10.1038/s41598-017-03700-1
PMID:28620195
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5472632/
Abstract

C5aR signaling plays an important role in the regulation of T cell activation and alloimmune responses in chronic graft-versus-host disease (cGVHD). However, direct evidence of this modulation and the efficacy of C5aR blockade in the treatment of cGVHD have not been demonstrated. We observed higher expression of C5aR on both monocytes and T cells of patients with cGVHD compared with healthy controls and non-GVHD patients after allogeneic hematopoietic stem cell transplantation. Our data also demonstrated a significant negative correlation between C5aR expression and regulatory T cells (Treg) frequency in cGVHD patients, indicating a potential role of C5aR in the generation and regulation of Treg. In addition, an in vitro experiment revealed C5aR deficiency promoted the development of Treg whereas C5a activation abolished the differentiation of Treg. Importantly, we found C5aR blockade by PMX53 attenuated the pathology of cGVHD and improved the survival of cGVHD mice. PMX53 had a direct regulatory effect on Treg commitment and increased TGF-β1 expression. Thus, C5aR signaling may induce and intensify cGVHD by down-regulating Treg induction. The modulation of C5aR activation by PMX53 may provide a potential therapy for cGVHD.

摘要

C5aR 信号在慢性移植物抗宿主病(cGVHD)中调节 T 细胞激活和同种免疫反应中发挥重要作用。然而,尚未证明这种调节的直接证据以及 C5aR 阻断在 cGVHD 治疗中的疗效。我们观察到,与健康对照者和异基因造血干细胞移植后的非 GVHD 患者相比,cGVHD 患者的单核细胞和 T 细胞上 C5aR 的表达更高。我们的数据还表明,cGVHD 患者 C5aR 表达与调节性 T 细胞(Treg)频率之间存在显著的负相关,表明 C5aR 在 Treg 的产生和调节中可能发挥作用。此外,体外实验表明 C5aR 缺乏促进了 Treg 的发展,而 C5a 的激活则消除了 Treg 的分化。重要的是,我们发现 PMX53 阻断 C5aR 减轻了 cGVHD 的病理学并改善了 cGVHD 小鼠的存活率。PMX53 对 Treg 的定向作用具有直接的调节作用,并增加了 TGF-β1 的表达。因此,C5aR 信号可能通过下调 Treg 的诱导而诱导和加剧 cGVHD。PMX53 对 C5aR 激活的调节可能为 cGVHD 提供一种潜在的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/1ac5857a1319/41598_2017_3700_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/c16128cb93a7/41598_2017_3700_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/5dc2187b27d3/41598_2017_3700_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/9eb5731c4b53/41598_2017_3700_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/e223c11a465c/41598_2017_3700_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/1ac5857a1319/41598_2017_3700_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/c16128cb93a7/41598_2017_3700_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/5dc2187b27d3/41598_2017_3700_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/9eb5731c4b53/41598_2017_3700_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/e223c11a465c/41598_2017_3700_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01d/5472632/1ac5857a1319/41598_2017_3700_Fig5_HTML.jpg

相似文献

1
Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg.C5a/C5aR 阻断可减轻 cGVHD,其机制与 Treg 频率增加有关。
Sci Rep. 2017 Jun 15;7(1):3603. doi: 10.1038/s41598-017-03700-1.
2
Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.补体 C3a 和 C5a 受体通过抑制受者树突状细胞的线粒体自噬来促进移植物抗宿主病。
JCI Insight. 2018 Dec 20;3(24):121697. doi: 10.1172/jci.insight.121697.
3
Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.缺乏 C3aR 和 C5aR 向 CD4⁺ 细胞发出信号会导致自诱导 TGF-β1 信号和 Foxp3⁺ 调节性 T 细胞的诱导。
Nat Immunol. 2013 Feb;14(2):162-71. doi: 10.1038/ni.2499. Epub 2012 Dec 23.
4
Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.过敏毒素受体C3aR和C5aR在肺纤维化发病机制中的作用。
FASEB J. 2016 Jun;30(6):2336-50. doi: 10.1096/fj.201500044. Epub 2016 Mar 8.
5
Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.补体 C5a 受体通过改变转移灶中的 T 细胞反应促进癌症转移。
Cancer Res. 2014 Jul 1;74(13):3454-65. doi: 10.1158/0008-5472.CAN-14-0157. Epub 2014 May 1.
6
C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.在急性肝衰竭中,C5a/C5aR途径对于通过激活p38丝裂原活化蛋白激酶(p38-MAPK)上调鞘氨醇激酶1(SphK1)的表达至关重要。
World J Gastroenterol. 2016 Dec 14;22(46):10148-10157. doi: 10.3748/wjg.v22.i46.10148.
7
Emerging role of C5a/C5aR IL-17A axis in cGVHD.C5a/C5aR-白细胞介素-17A轴在慢性移植物抗宿主病中的新作用
Am J Transl Res. 2018 Jul 15;10(7):2148-2157. eCollection 2018.
8
Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.间充质干细胞通过下调C5a/C5aR途径的激活来减轻急性肾损伤。
Int Urol Nephrol. 2018 Aug;50(8):1545-1553. doi: 10.1007/s11255-018-1844-7. Epub 2018 Mar 28.
9
Role of C5a-C5aR interaction in sepsis.C5a-C5aR相互作用在脓毒症中的作用。
Shock. 2004 Jan;21(1):1-7. doi: 10.1097/01.shk.0000105502.75189.5e.
10
C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.C5a/C5aR 通路通过下调 PGRN 表达加速肾缺血再灌注损伤。
Int Immunopharmacol. 2017 Dec;53:17-23. doi: 10.1016/j.intimp.2017.10.006. Epub 2017 Oct 12.

引用本文的文献

1
Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies.口腔慢性移植物抗宿主病:发病机制、诊断、当前治疗和新兴疗法。
Int J Mol Sci. 2024 Sep 27;25(19):10411. doi: 10.3390/ijms251910411.
2
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement.一项 C5a 补体抑制剂治疗急性移植物抗宿主病伴下消化道受累的前瞻性 2 期临床试验。
Bone Marrow Transplant. 2023 Sep;58(9):991-999. doi: 10.1038/s41409-023-01996-4. Epub 2023 May 18.
3
The Gut Bacteria Dysbiosis Contributes to Chronic Graft-Versus-Host Disease Associated With a Treg/Th1 Ratio Imbalance.

本文引用的文献

1
Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner.治疗性调节性T细胞过继性转移以CXCR5依赖的方式改善已建立的小鼠慢性移植物抗宿主病。
Blood. 2016 Aug 18;128(7):1013-7. doi: 10.1182/blood-2016-05-715896. Epub 2016 Jul 6.
2
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.辅助性 T 细胞 1 型免疫需要补体驱动的 CD4⁺ T 细胞中的 NLRP3 炎性体活性。
Science. 2016 Jun 17;352(6292):aad1210. doi: 10.1126/science.aad1210.
3
Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application.
肠道细菌失调导致与Treg/Th1比例失衡相关的慢性移植物抗宿主病。
Front Microbiol. 2022 Sep 8;13:813576. doi: 10.3389/fmicb.2022.813576. eCollection 2022.
4
[Artesunate attenuate chronic graft-versus-host disease by regulating Th17/Treg balance].青蒿琥酯通过调节Th17/Treg平衡减轻慢性移植物抗宿主病
Zhonghua Xue Ye Xue Za Zhi. 2019 Jan 14;40(1):63-68. doi: 10.3760/cma.j.issn.0253-2727.2019.01.012.
5
Attenuation of murine sclerodermatous models by the selective S1P receptor modulator cenerimod.西尼莫德减弱鼠类硬皮病模型。
Sci Rep. 2019 Jan 24;9(1):658. doi: 10.1038/s41598-018-37074-9.
6
A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD.间充质基质细胞衍生的外泌体在预防移植物抗宿主病中的免疫调节作用。
J Hematol Oncol. 2018 Dec 7;11(1):135. doi: 10.1186/s13045-018-0680-7.
7
C5a Blockade Increases Regulatory T Cell Numbers and Protects Against Microvascular Loss and Epithelial Damage in Mouse Airway Allografts.C5a 阻断可增加调节性 T 细胞数量,并防止小鼠气道同种异体移植物的微血管丢失和上皮损伤。
Front Immunol. 2018 May 24;9:1010. doi: 10.3389/fimmu.2018.01010. eCollection 2018.
牙周炎临床前模型中的补体抑制及临床应用前景
Semin Immunol. 2016 Jun;28(3):285-91. doi: 10.1016/j.smim.2016.03.006. Epub 2016 Mar 24.
4
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目:I. 2014年诊断与分期工作组报告
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18.
5
C5a and bradykinin receptor cross-talk regulates innate and adaptive immunity in Trypanosoma cruzi infection.C5a 和缓激肽受体相互作用调节克氏锥虫感染中的先天和适应性免疫。
J Immunol. 2014 Oct 1;193(7):3613-23. doi: 10.4049/jimmunol.1302417. Epub 2014 Sep 3.
6
Insights into the mechanism of C5aR inhibition by PMX53 via implicit solvent molecular dynamics simulations and docking.通过隐式溶剂分子动力学模拟和对接对PMX53抑制C5aR机制的洞察
BMC Biophys. 2014 Aug 12;7:5. doi: 10.1186/2046-1682-7-5. eCollection 2014.
7
Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus.补体成分 C5a 允许致病性 Th17 细胞和 I 型 IFN 在狼疮中共存。
J Immunol. 2014 Oct 1;193(7):3288-95. doi: 10.4049/jimmunol.1401322. Epub 2014 Aug 22.
8
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.慢性移植物抗宿主病和闭塞性细支气管炎需要增加滤泡辅助性T细胞和生发中心B细胞。
Blood. 2014 Jun 19;123(25):3988-98. doi: 10.1182/blood-2014-03-562231. Epub 2014 May 12.
9
Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.补体成分C3在人T细胞活化和皮肤移植物抗宿主病中介导Th1/Th17极化。
Bone Marrow Transplant. 2014 Jul;49(7):972-6. doi: 10.1038/bmt.2014.75. Epub 2014 Apr 28.
10
Complement anaphylatoxins as immune regulators in cancer.补体过敏毒素作为癌症中的免疫调节因子
Cancer Med. 2014 Aug;3(4):747-58. doi: 10.1002/cam4.241. Epub 2014 Apr 8.